Posted on : Dec.11,2018 17:27 KST

Following the Korea Exchange’s decision to lift the suspension on trading Samsung BioLogics shares on the KOSPI listing, prices for the company’s shares have risen. Sales resumed on Dec. 11 at a price of 398,500 won (US$352.66) per share, exhibiting a 19.13% increase from its trading price before the suspension. It also climbed back to its number five spot in South Korea’s market capitalization rankings.

original

  • 오피니언

multimedia

most viewed articles

hot issue